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Background: Although hyperlipidemia is known as a risk factor of stroke, its effects on the outcome are unknown.
The aim of the study is to clarify the influences of hyperlipidemia on the stroke early outcome by estimating odds
ratio (OR) for sequelae requiring care and hazard ratio (HR) for death.
Methods: A total of 12617 stroke patients registered in the Kyoto Stroke Registry with information on a hyperlipidemia
history. We compared patients who had hyperlipidemia history and patients who hadn’t. The OR for remaining
sequelae requiring certain care on 30 day after stroke was calculated using a logistic regression in stroke as a whole
and in each stroke subtype; cerebral infarction (CI), cerebral hemorrhage (CH) and subarachnoid hemorrhage (SAH).
The HR for death within 30 day after stroke was estimated by the Cox regression.
Results: The OR (95% confidence interval) for remaining sequelae 30 days after stroke was 0.66 (0.60-0.73, p < 0.001) in
patients with hyperlipidemia history compared with patients without hyperlipidemia history. After stratified by stroke
subtypes, it was 0.75 (0.67-0.85, p < 0.001) in CI, 0.59 (0.45-0.77, p < 0.001) in CH and 0.77 (0.43-1.38, p = 0.767) in SAH.
The HR (95% confidence interval) for death was 0.39 (0.31-0.48, p < 0.001) in patients with hyperlipidemia history
comparing patients without hyperlipidemia history. After stratified by stroke subtypes, it was 0.45 (0.32-0.63, p < 0.001)
in CI, 0.64 (0.44-0.93, p = 0.018) in CH and 0.76 (0.47-1.23, p = 0.264) in SAH. Each value was adjusted for age and sex.
Conclusions: This study suggests that the outcome is favorable for patients with hyperlipidemia history in terms of
both remaining sequelae and HR for death. A factor which increases the incidence of the disease could influence on
the severity of the disease in a favorable way.
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Elevated levels of cholesterol are reported to be associa-
ted with increased rate of recovery from ADL disability
[1]. Hyperlipidemia is one of the major risk factors for
atherosclerosis [2,3]. A risk factor is regarded as a factor
which increases the incidence of a disease [4-9]. Hy-
perlipidemia is a well-known risk factor for vascular
diseases such as stroke and myocardial infarction. Long
term expose to the risk factors promotes atherosclerosis
and subsequently develops stroke. Complex of factors
should be involved in the stroke pathogenesis and the* Correspondence: neuron.k07@gmail.com
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the development of stroke. Risk factors have been dis-
covered by comparing the incidences of the disease bet-
ween two groups; a group with a factor and a group
without a factor. If the incidence in a group with a factor
is higher than in another group without it, the factor is
regarded as a risk factor. Severity of the disease is not
necessarily taken into consideration in this process.
However, when considering stroke, not only the inci-
dence but also the severity are precious, for stroke is im-
portant not only as a major cause of death but also as a
major cause of sequelae requiring care, which are heavy
burden for patients, for caregivers and for the society.
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fluence on the severity of stroke is interesting and
worthwhile to investigate [10]. To clarify the relationship
between a risk factor and a severity of the disease is im-
portant because it gives tips to understand the pathoge-
nesis of the disease and leads to the prevention. Besides,
among hospitalized disabled older adults, elevated levels
of cholesterol are associated with increased rate of re-
covery from ADL disability [1].
The Kyoto Stroke Registry has a large amount of data
of stroke patients with information on hyperlipidemia
history and on early outcome; degrees of sequelae and
mortality. Based on the registry data, we calculated the
odds ratios (OR) for remaining sequelae after 30 days of
stroke and the hazard ratios (HR) for death within
30 days. The aim of the study is to investigate the effects
of hyperlipidemia history on early outcome of stroke
and, by doing so, to answer the question whether a risk
factor could affect the outcome of the disease.
Methods
We reviewed all stroke patients with information on
hyperlipidemia history identified in the Kyoto Stroke
Registry (KSR) from January 1999 to April 2009. The de-
tails of KSR have been previously reported [11-15]. The
KSR has been keeping efforts to grasp the state of stroke
patients in Kyoto Prefecture aiming at promotion of
countermeasures against stroke from the prevention to
rehabilitation to improve impairment as much as pos-
sible to avoid staying in hospitals and facilities and re-
turn to home. Stroke patients are registered in KSR in
cooperation with all medical institutions belonging toTable 1 Summary of the stroke patients in the study cohort
Stroke (n = 12617)
Age (mean ± SD) 71.2 ± 12.9
Sex (men % (n)) 55.2 (6962)








Systolic blood pressure (mean ± SD) 160.9 ± 31.2
Diastolic blood pressure (mean ± SD) 87.5 ± 18.8
Hypertension history, with % (n) 61.8 (7585)
Diabetes mellitus history, with % (n) 20.4 (2545)
Cigarette smoking, with % (n) 32.3 (3440)
Alcohol consumption, with % (n) 38.1 (3967)




Mortality, dead % (n) 8.3 (1047)the Kyoto Medical Association to investigate the actual
state of stroke patients in Kyoto Prefecture. The Kyoto
Medical Association (KMA) distributes the registration
form to all cooperative facilities, and physicians in
charge at cooperative facilities fill the form and send it
back to the KMA. The registration items include age,
sex, date of onset, past medical histories (hypertension,
diabetes mellitus (DM), and hyperlipidemia), cigarette
smoking and alcohol consumption, blood pressure on
consultation, presence or absence of arrhythmia, con-
sciousness level based on the Japan Coma Scale (JCS)
[11] and history of examinations (CT, MRI), activity of
daily life (ADL) at day 30 after the development, pre-
sence or absence of dementia, and survival. Information
on the past medical histories was obtained from the
patients/their families and from the medical records.
Stroke was classified into 3 major subtypes; cerebral
infarction (CI), cerebral hemorrhage (CH), and sub-
arachnoid hemorrhage (SAH) according to the WHO
definition [16].
We used the following definitions:
1. Systolic and diastolic hypertension: blood pressure
is 140 and 90 mm Hg or higher;
2. Diabetes mellitus: fasting plasma glucose is
126 mg/dl or higher, and/or plasma glucose 2 h
after 75 g glucose load is 200 mg/dl or higher;
3. Hyperlipidemia: serum cholesterol level is
220 mg/dl or higher and/or triglyceride is
150 mg/dl or higher.
4. Arrhythmia: any types of irregularity of heart beats




71.5 ± 13.2 69.8 ± 11.1
55.9 (5696) 52.3 (1266)





160.6 ± 31.5 162.3 ± 29.6
87.3 ± 18.8 88.5 ± 18.7
57.5 (5694) 79.7 (1891)
17.0 (1724) 34.6 (821)
31.8 (2702) 34.4 (738)





9.4 (957) 3.7 (89)
Table 2 OR for remaining the state requiring certain care




95% confidence interval p
Lower Upper
Stroke 0.659 0.596 0.729 <0.001
Cerebral infarction 0.764 0.680 0.858 <0.001
Cerebral hemorrhage 0.650 0.503 0.840 0.001
Subarachnoid hemorrhage 0.825 0.469 1.449 0.502
Adjusted for age and sex.
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in Japan:
1. ADL1 (No symptoms or no significant disability),
independent gait;
2. ADL2 (Mildly disabled condition), a cane is
necessary for gait;
3. ADL3 (Moderately disabled condition), assistance is
necessary for gait; and
4. ADL4 (Severely disabled condition), a bedridden
state. The date of death was registered when the
patient died within 30 days after the event.
Based on information obtained from the patients and
their families and on medical records, the patients were
classified into 2 groups; those who have hyperlipidemia
history (HL) and those who had not (NL).
Statistical analyses
The frequencies of characteristics in HL and NL were
determined and evaluated for univariate associations by
χ square analysis. Numerical data such as age and blood
pressure were compared with a student-t test. The OR
for sequelae requiring certain care was calculatedFigure 1 Kaplan-Meier survival curves of patients with cerebral infarccomparing HL with NL using a logistic regression in
stroke as a whole and in each stroke subtype, CI, CH
and SAH after adjustment for age and sex. The HR
for death within 30 days after stroke was estimated
comparing HL with NL using the Cox regression. Each
value was adjusted for age and sex. The OR was calcu-
lated as eβ with 95% CI = e(β±1.96×SE). Here, “β” is the re-
gression coefficient corresponding to LD or HD (with
AB as a reference), and “SE” is the standard error of “β”.
No multiplicity adjustment was applied in principal be-
cause a significant difference was detected in the above χ
square test and to reduce the error of the second kind,
i.e. to reduce the risk of overlooking differences. Ana-
lyses were performed using SPSS ver.19 (IBM). All re-
ported p values were 2-sided. Statistical significance was
set at p < 0.05.
This research was performed in accordance with the
ethical principles for medical research involving human
subjects outlined in the Declaration of Helsinki. This
research was approved by the Board of Directors, the
Kyoto Medical Association, the Department of Health and
Welfare, Kyoto Prefecture and the Ethics Committee of the
National Hospital Organization, Minami Kyoto Hospital.
Since all identifying personal information was stripped
from the secondary files before analysis, the boards waived
the requirement for written informed consent from the
patients involved.
Results
We reviewed a total of 12617 patients with information
on the hyperlipidemia history. Patients’ characteristics
are summarized in Table 1. The significance of the dif-
ference of each variable between patients with hyperli-
pidemia and patients without hyperlipidemia are shown
in Additional file 1: Table S1. The ORs for consciousness
disturbance at the onset of stroke comparing patients
with hyperlipidemia to patients without hyperlipidemiation (p < 0.001).
Figure 2 Kaplan-Meier survival curves of patients with cerebral hemorrhage (p = 0.004).
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vided in Additional file 2: Table S2. Most of patients in
the study cohort had CT or MRI or both. Neither CT
nor MRI was performed in 99 patients; at least one was
performed in 99.2% of the patients.
The OR for remaining sequelae after 30 days of stroke
(i.e. ADL 2–4 compared with ADL1) using NL as a
reference was 0.66 (0.60-0.73, p < 0.001). After stratified
by stroke subtypes, it was 0.76 (0.68-0.86) in CI, 0.65
(0.50-0.84, p < 0.001) in CH and 0.83 (0.47-1.45, p = 0.502)
in SAH. They are summarized in Table 2.
Mortality within 30 days after stroke was lower in HL
(3.7%, 89 out of 2411) than in NL (9.4%, 958 out of
10170). The number of missing data on survival infor-
mation was 8 out of 2419 in HL and 28 out of 10198 in
NL, respectively.
The Kaplan-Meier Survival curves comparing HL and
NL with a log-rank test in CI, in CH and in SAH are
presented in Figures 1, 2 and 3, respectively.
The HR for death within 30 days was 0.39 (0.31-0.48,
p < 0.001) in stroke. After stratified by stroke subtypes,
it was 0.45 (0.32-0.63, p < 0.001) in CI, 0.64 (0.44-0.93,Figure 3 Kaplan-Meier survival curves of patients with subarachnoidp = 0.018) in CH and 0.76 (0.47-1.23, p = 0.264) in SAH.
Each value was adjusted for age and sex. They are sum-
marized in Table 3. Frequency of hyperlipidemia patients
with or without medication in the study cohort is shown
in Additional file 3: Table S3. The HRs for death within
30 days after stroke in patients with hyperlipidemia
compared to patients without hyperlipidemia and com-
pared to with and without medication for hyperlipidemia
estimated using the Cox regression are summarized in
Additional file 4: Table S4.
Discussion
Both the OR for remaining sequelae after stroke and the
HR for death were lower in HL than in NL irrespective
of age and sex, indicating that hyperlipidemia history
had a favorable influence on the early outcome of stroke.
Since the early outcome largely depends on the severity
of stroke, the results suggest that hyperlipidemia history
has a favorable effect on the severity of stroke. As a risk
factor, hyperlipidemia history increases the incidence of
stroke. Nevertheless, it might make the disease less
severe. The great portion of progress of atherosclerosishemorrhage (p = 0.302).
Table 3 Hazard ratios for death within 30 days after




95% confidence interval p
Lower Upper
Stroke 0.386 0.310 0.480 <0.001
Cerebral infarction 0.450 0.323 0.626 <0.001
Cerebral hemorrhage 0.641 0.444 0.926 0.018
Subarachnoid hemorrhage 0.760 0.470 1.230 0.264
Adjusted for age and sex.
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obstruction in cerebral flow arises to develop brain func-
tional damage. So, it could be more serious in degree
without being symptomatic and the contrary is also the
same. Hyperlipidemia accelerates damage on a certain
cerebral artery and makes atherosclerosis symptomatic.
Possible interpretation, therefore, includes that hyper-
lipidemia developed stroke at rather early stage of the
disease “atherosclerosis”. Namely, hyperlipidemia could
develop less serious stroke.
This study showed similar results in CI and CH, not in
SAH. Although both CI and CH are the same at the
point that they are cerebrovascular disorder based on
cerebral arterial deterioration, the pathology of the two
is mutually the opposite. The former is the obstruction
of the artery and the latter is the rupture of it. There
could be differences of the effects of hyperlipidemia on
the two distinct pathologies. Iso et al. reported that there
was an inverse relation between the serum cholesterol
level and the risk of death from hemorrhagic stroke in
middle-aged American men [17]. They admitted the
positive association of higher serum cholesterol levels
with death from nonhemorrhagic stroke and total car-
diovascular disease. Elevated levels of cholesterol are re-
ported to be associated with increased rate of recovery
from ADL disability [1]. Hyperlipidemia might develop
stroke at rather early stage of arteriosclerosis, including
less serious stroke.
Major determinants of stroke outcome include age
[18], sex [19-21], treatments and severity at the onset.
The age and sex were adjusted in the study. The bias
due to differences in treatments is unavoidable and we
could not adjust for them. However, since treatment ac-
cording to the guidelines is performed and the govern-
mental medical insurance for the whole nation covers all
people in Japan, a treatment bias is not very much likely.
Embolism could lead a poor outcome without hyperli-
pidemia [22,23]. However, influence of embolism should
be predominantly on CI. The differences are supposed
to be based on the severity of the disease in principle
[24]. So, hyperlipidemia history is thought to have an
effect on stroke severity. Since the severity of strokecould largely depend on the size and location of the le-
sion [10,25], effects of hyperlipidemia on cerebral arte-
ries may be different among their sizes and locations.
Further studies to clarify the associations between the
size and location of the brain lesion and hyperlipidemia
are promising and should be feasible at stroke centers
with MRI for example.
The study may have all the limitations that a re-
trospective cohort study could have. The definition of
hyperlipidemia in the KSR includes both high level of
serum cholesterol and triglyceride, which was a standard
in Japan during the period of this survey. Therefore, it is
difficult to understand which, cholesterol or triglyceride,
accounts for the association. The study with a large co-
hort together with the previous reports suggests an asso-
ciation between serum lipid and outcome of stroke.
In this study, since analysis was performed using a
stroke registry, the subjects consisted of stroke patients.
The results were “relative” ones obtained using a certain
subgroup (NL in principle) as a reference. For example, a
significantly lower OR in HL compared with NL can also
be interpreted as a higher OR in NL compared with HL.Conclusion
The study showed that the presence/absence of hyperli-
pidemia history was associated with the outcome of both
CI and CH in a favorable manner, irrespective of the age
and sex. A risk factor, which increases the incidence of a
disease, may influence on the severity of a disease, even
inversely and favorably.Additional files
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